Eli Lilly expects to miss mark in fourth quarter

Article Abstract:

Eli Lilly and Co. is forecasting lower-than-expected results for the 2001 fourth-quarter. The company, which has been hurt by the sales decline in its antidepressant drug, also forecasted low results for the fiscal 2001 and 2002 periods.

Forecasts and trends, Eli Lilly and Co., LLY

---

Bristol-Myers earnings rise on strong U.S. sales

Article Abstract:

Bristol-Myers Squibb Co. posted strong earnings for the 1999 fourth-quarter. The company's earnings per diluted share increased more than one-and-a-half times from 20 cents in 1998 to 52 cents in 1999.

---

Bristol-Myers says net increased 11%, meeting estimates

Article Abstract:

Bristol-Myers Squibb Co. posted an increase of 11% in their net income for the 2000 fourth-quarter. The company posted $1.16 billion (1.23 billion euros) in net income for the period.

Similar abstracts:

• Abstracts: Phelps Dodge's net beats estimates in third quarter. AngloGold net increases 2%. Angloplats, Impala expected to post strong earnings
• Abstracts: KPNQwest's results beat expectations for third quarter. ASML reports a net loss, says outlook is uncertain. Libertel reports 20% net rise, helped by customer growth
• Abstracts: Crossgain fires about a quarter of its employees. BEA to buy Crossgain in deal estimated at $30 million. U.S. files an antitrust suit to halt Compuware deal
• Abstracts: Preussag posts pretax profit rise in core activities. Preussag's net climbs 42%, buoyed by core business. Preussag continues expanding travel sector
• Abstracts: U.S. files charges in North Korean counterfeit probe. Iran reopens nuclear facility, drawing rebuke

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.